U.S. regulators approve Wegovy pill for weight loss

U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

US health agency unveils weight-loss drug coverage model

U.S. President Donald Trump, Eli Lilly (LLY.N) and Novo Nordisk (NOVOb.CO) signed a deal in November to slash the prices of ...

Medicare opens door to covering blockbuster drugs for weight loss

Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...
New Atlas

First GLP-1 weight-loss pill on sale in the US within weeks for $149 a month

The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving ...

FDA approves Wegovy pill for weight loss, the first daily oral medication of its kind

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
Everyday Health

First GLP-1 Pill for Weight Loss Gets FDA Approval

This new pill contains the same active ingredient as injectable Wegovy and Ozempic, semaglutide. It is the first GLP-1 pill ...

New Wegovy pill offers needle-free weight loss — but may not work for everyone

The FDA has approved the first-ever Wegovy pill for weight loss, with the oral GLP-1 offering a 16.6% average weight ...
Audacy on MSN

FDA approves a pill version of the weight-loss drug Wegovy: what to know

Everyone hoping for a slimmed down 2026 got a boost with the news the US Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy, making it the first in this new era.
NDTV

Diabetes, Weight Loss Drug Ozempic Launched In India: See Dosage, Price And More

Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at Rs 8,800 a month or four weeks. Ozempic-- a once-weekly injectable formulation of semaglutide -- is ...
Finanznachrichten

Novo Nordisk A/S: More efficacious dose of Wegovy recommended by the European Medicines Agency can help people with obesity achieve an average of 20.7% weight loss

The European Medicines Agency (EMA) has issued a positive opinion for a new Wegovy 7.2 mg dose, advancing its availability in the European Union (EU) In the STEP UP programme, people with obesity ...
Pragativadi

Ozempic Launched in India: Prices, Dosage, and Key Details of Novo Nordisk’s Diabetes and Weight-Loss Drug

Novo Nordisk has officially launched its globally known diabetes and weight-management drug, Ozempic, in India. The once-weekly injectable treatment will be available starting at ₹8,800 for a ...
Frontiers

Metformin for primary prevention of colorectal neoplasms in adenoma-free populations: a systematic review and dose-response meta-analysis

Background: Metformin shows promise in preventing colorectal cancer (CRC) and its precursors, but evidence on its dose-response effect remains limited. Aim: To determine the association between ...